|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 489/02 | |
| C07D 489/08 | |||
| A61K 31/485 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2475429 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10815769.4 |
| Europos patento paraiškos padavimo data | 2010-04-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-07-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-07-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/031956 |
| Data | 2010-04-21 |
| (87) | Numeris | WO 2011/031350 |
| Data | 2011-03-17 |
| (30) | Numeris | Data | Šalis |
| 240611 P | 2009-09-08 | US | |
| 288148 P | 2009-12-18 | US |
| (72) |
JENKINS, Thomas E., US
HUSFELD, Craig O., US
SEROOGY, Julie D., US
WRAY, Jonathan W., US
|
| (73) |
Signature Therapeutics, Inc.,
1731 Embarcadero Road, Suite 200, Palo Alto, CA 94303,
US
|
| (54) | COMPOSITIONS COMPRISING ENZYME-CLEAVABLE KETONE-MODIFIED OPIOID PRODRUGS AND OPTIONAL INHIBITORS THEREOF |
| COMPOSITIONS COMPRISING ENZYME-CLEAVABLE KETONE-MODIFIED OPIOID PRODRUGS AND OPTIONAL INHIBITORS THEREOF |